Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Geneva Capital Management LLC

Geneva Capital Management LLC lessened its stake in Azenta, Inc. (NASDAQ:AZTA) by 0.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 511,923 shares of the company’s stock after selling 2,097 shares during the quarter. Geneva Capital Management LLC owned about 0.92% of Azenta worth $33,347,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Retirement Systems of Alabama increased its holdings in shares of Azenta by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 75,339 shares of the company’s stock valued at $4,908,000 after purchasing an additional 230 shares during the last quarter. Headlands Technologies LLC grew its stake in shares of Azenta by 35.6% in the fourth quarter. Headlands Technologies LLC now owns 883 shares of the company’s stock valued at $58,000 after buying an additional 232 shares in the last quarter. Covestor Ltd grew its stake in shares of Azenta by 17.5% in the third quarter. Covestor Ltd now owns 1,714 shares of the company’s stock valued at $86,000 after buying an additional 255 shares in the last quarter. Raymond James & Associates grew its stake in shares of Azenta by 0.3% in the fourth quarter. Raymond James & Associates now owns 96,126 shares of the company’s stock valued at $6,262,000 after buying an additional 285 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its stake in shares of Azenta by 8.7% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 5,100 shares of the company’s stock valued at $256,000 after buying an additional 408 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of several analyst reports. B. Riley boosted their target price on Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Jefferies Financial Group initiated coverage on Azenta in a research note on Thursday, April 4th. They set a “hold” rating and a $64.00 target price for the company. Needham & Company LLC lowered their target price on Azenta from $75.00 to $69.00 and set a “buy” rating for the company in a research note on Thursday. Evercore ISI decreased their price target on Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a report on Thursday, April 4th. Finally, Stephens reaffirmed an “equal weight” rating and set a $70.00 price target on shares of Azenta in a report on Thursday, February 8th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Azenta currently has a consensus rating of “Hold” and an average target price of $68.40.

Azenta Trading Down 2.9 %

Shares of Azenta stock traded down $1.56 on Thursday, hitting $52.51. The stock had a trading volume of 1,343,192 shares, compared to its average volume of 441,225. Azenta, Inc. has a 52-week low of $36.01 and a 52-week high of $69.16. The stock has a market cap of $2.93 billion, a price-to-earnings ratio of -165.58 and a beta of 1.51. The company’s 50 day moving average price is $57.68 and its 200 day moving average price is $59.22.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, May 8th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The business had revenue of $159.13 million during the quarter, compared to the consensus estimate of $159.89 million. During the same period in the previous year, the business earned ($0.06) EPS. The business’s quarterly revenue was up 7.2% on a year-over-year basis. Analysts predict that Azenta, Inc. will post 0.27 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.